Rapid Micro Biosystems closed at $0.68 on Nov 4, down 1.53%, within 0.0% of its 52-week closing low. Volume of 209.2K shares was 1.40× its 20-day average (above normal).
Split-adjusted performance: -27.7% over one month, -73.1% over six months, -75.2% over one year.
In the quarter ended Jun 30, 2026, revenue was $8.05M, up 10.9% from a year earlier, with a net margin of -160.5%.
Short interest was 888.6K shares at the Oct 15 settlement, up 4.1% from the prior report (3.9% of float, 3.8 days to cover).